Wellnex Life (ASX:WNX) said its revenue for January and February was up 89% to AU$4.2 million compared to a year earlier, with brand sales up 46% to almost AU$3 million compared to the prior year and IP licensing up 600% to AU$1.2 million, according to a Friday Australian bourse filing.
Gross margin in the first two months of the year was up 45% to $1.4 million compared with AU$1 million last year, with normalized operational profit in February of about AU$220,000, contributing to a rise in the first two months of 92%, with a normalized loss of AU$35,000 compared with a loss of AU$370,000 last year, the filing added.
The company said its proposed dual listing on the Alternative Investment Market (AIM) of the London Stock Exchange is in the final stages with the proposed publication of the AIM admission document expected early next week.
The company's shares slid 2% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.